Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070463
Filing Date
2025-05-13
Accepted
2025-05-13 16:40:52
Documents
61
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgx-20250331.htm   iXBRL 10-Q 2543954
2 EX-31.1 mgx-ex31_1.htm EX-31.1 17680
3 EX-31.2 mgx-ex31_2.htm EX-31.2 17703
4 EX-32.1 mgx-ex32_1.htm EX-32.1 15376
  Complete submission text file 0000950170-25-070463.txt   9483276

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20250331.xsd EX-101.SCH 1379288
64 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20250331_htm.xml XML 1546766
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41949 | Film No.: 25940859
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)